Radiotherapy or Imiquimod in Complex Lentigo Maligna
Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effectiveness of using either radiotherapy
(RT) or Imiquimod (ImiQ) to treat the Lentigo Maligna (LM), when surgery is not possible, is
refused, or fails.
Phase:
Phase 3
Details
Lead Sponsor:
Australia and New Zealand Melanoma Trials Group Melanoma and Skin Cancer Trials Limited